Attachment C Reference Lab SOW BVAMC RFQ.docx

DOCX document 132 KB Posted

Attached to
Q301 Reference Laboratory Testing Boise VA Medical Center
Solicitation number
36C26026Q0236
Issued by

About this file

This is a Statement of Work (SOW) for Reference Laboratory Services at the Boise VA Medical Center, covering comprehensive laboratory testing services. The SOW requires a reference laboratory to provide clinical chemistry and microbiology services, including specimen processing, analysis, reporting, and consultation, with a period of performance starting 03/01/2026. Key requirements include maintaining a fully functioning electronic data interface with VA's VISTA computer system, providing courier services for specimen transport, ensuring compliance with federal regulations and accreditation standards, and meeting specific turnaround times for test results (generally 1-5 days for clinical chemistry and 2-5 days for microbiology).

The document details extensive requirements for laboratory services, including providing all necessary supplies, maintaining 95% proficiency testing success rates, protecting patient health information, and supporting electronic data exchange with HIPAA-compliant encryption. The reference laboratory must supply a comprehensive test menu of over 300 different tests, ranging from drug monitoring and infectious disease testing to specialized molecular and genetic analyses. Performance will be monitored by a Contracting Officer Representative who will review quality of service, turnaround times, billing accuracy, and customer service, with potential contract termination for repeated performance failures.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

STATEMENT OF WORK (SOW) for Reference Laboratory Services Boise VAMC Laboratory

1. SCOPE

a. The Reference Laboratory shall provide in accordance with all applicable federal, state, and local regulations, laws, and ordinances, and in accordance with the specifications outlined for accreditation certification if applicable, patient specimen testing for the specific range of referral testing within their capability.

b. Services shall include the performance of analytical testing as defined by the Laboratory's reference test manual, the reporting of analytical test results and consultative services as required assimilating the full scope of its laboratory operations to Boise VA Laboratory Services.

c. All requirements and provisions defined in the specifications of this solicitation will apply to any laboratory, i.e. branch, division, sub-contractor, etc. performing reference testing on behalf of the Reference Laboratory.

d. The VA Facilities will be responsible for specimen collection and will provide laboratory specimens prepared according to the Reference Laboratory's laboratory user’s manual, identified, and labeled for testing.

e. Period of performance starts 03/01/2026

2. SPECIFIC TASKS

a. Clinical Chemistry:

i. Reference Laboratory shall provide laboratory services to include: preanalytic processing as defined in Reference Laboratory published user’s manual; analysis, reporting of analytic results and interpretation of analytic clinical results. The number of tests requested under this contract will change throughout the life of the contract. The volumes or amounts shown in the solicitation are estimates only and impose no obligation on the VA.

ii. The Reference Laboratory shall also provide the following support services: supplies, customer service, courier service (to include pickup of specimens and transport of specimens to its laboratory), reporting services, and verification of certification. See Section 12.

iii. Provide all necessary supplies as defined in the laboratory user manual, to include, but not limited to the following:

1) Requisition forms or agreed computer ordering system

2) Specimen containers

3) Dry ice and appropriate container

4) Special instructions

5) Log books for samples sent out and results returned

6) Specimen carriers

7) All forms, including Chain of Custody forms

8) Special media or tubes for viral samples

9) All supplies for special tests (e.g., but not limited to, viral studies), including 24-hour urine containers with preservatives.

iv. The Reference Laboratory shall provide to the VA Facilities the supplies and equipment within one (1) week of receipt of the delivery order. The VA Facilities will request replenishment of supplies from the Reference Laboratory on an as needed basis via telephone or fax. A confirmation of the order shall be supplied to the VA within 24 hours.

v. All supplies shall be shipped FOB Destination.

b. Microbiology:

i. If required, the Reference Laboratory shall provide microbiology services for Boise VA Medical Center. The number of tests requested under this contract will change throughout the life of the contract.

ii. Contractor shall provide laboratory services for Microbiology to include pickup and transport of specimens from the Boise VA to its laboratory; pre-analytic processing as defined in its laboratory user’s manual; analysis, reporting of analytic results, and consultation regarding selection, collection, transportation and result interpretation. The contractor shall provide the following supplies/materials:

1) Special instructions

2) Specimen carriers

3) Special media or tubes for viral samples

4) All supplies for specimen preservation, special tests (e.g., but not limited to, viral studies)

iii. Microbiology preliminary reports shall be provided within 24hrs

3. Electronic Interface

a. If awarded the Reference Laboratory agrees to a transition period for providing a fully functioning interconnection for exchanging data between VISTA, VA Computer system, and the Reference Laboratory's electronic lab information system. During this time the Reference Laboratory will supply the VA Facility with available test menu and agrees to receive test orders as they are transitioned until full menu implementation.

b. System drivers must be compatible with the VA’s Vista Laboratory Electronic Data Exchange (LEDI) software. The server and interface software will be owned and maintained by the Reference Laboratory. The Reference Laboratory must have a signed MOU (Memorandum of Understanding) with the VA Network and Security Operations Center (NSOC) to utilize the One- VA VPN Tunnel.

c. This interconnection shall be protected through the use of VA approved encryption algorithms and products as required and in compliance with HIPPA guidelines. Connections at each end shall be located within a controlled access facility. All access shall be controlled by authentication methods to validate approved users.

d. Agrees to provide one full-time support person for new interface if new vendor.

4. TESTING METHODOLOGY, REFERENCE AND TURN AROUND TIME

a. Routine test results shall be reported within the specified turnaround time (TAT) which is defined from time of specimen pickup to when results are available. TAT is established by the VA facility. In general, majority of Clinical Chemistry should be completed within 1-5 days, see attachment for details. In general, majority of Microbiology should be completed within 2-5 days, see attachment for details. If testing is not within TAT, notify the VA Facilities of the new estimated TAT within 12 hours.

b. Testing methodology and reference ranges for a test must be defined in the Reference Laboratory user manual and/or website. Reference Laboratory shall advise facility of any changes in methodology, procedure, reference ranges and any new tests introduced 30 days in advance.

c. Reference Laboratory agrees to maintain the minimum acceptable service, reporting systems and quality control. Exception handling: Reference Laboratory will notify VA Facilities Laboratory Service within 12 hours of any problems with specimens received.

d. The VA Facilities will provide laboratory specimens prepared according to the Reference Laboratory's user’s manual, identified, and labeled for testing.

e. Routine Microbiology test results shall be reported, preliminary at minimum, within 24 hours (within agreed TAT per each test). STAT test results shall be reported within 2 hours or less of specimen pick-up. Critical Value test results shall be reported immediately. Stat test results will be faxed or telephoned to Laboratory Service. Telephoned results will be confirmed with a follow-up by vendor via fax.

f. The Reference Laboratory will have the ability to provide STAT testing results (24-hour TAT) at a local laboratory, as needed.

5. CUSTOMER SERVICE

a. The Reference Laboratory will provide VA Laboratory with a means of communication to permit immediate inquiry regarding the status of pending tests or specimen problem, 24 hours per day, 7 days per week.

b. The Reference Laboratory shall provide names and telephone numbers of technical Directors and Pathologists available to provide information.

c. The Reference Laboratory will be required to provide on-site (BVAMC) training of Boise personnel for processing laboratory send out specimens if a new vendor is selected. This training shall be funded by the awarded Reference Laboratory at no expense to the Boise VAMC.

6. COURIER SERVICES

a. The Reference Laboratory shall be responsible for transporting and storing specimens in such a manner as to ensure stability and integrity of the specimen where applicable. Reference Laboratory shall supply any special preservatives required for specimen preservation.

b. Transport samples in such a manner as to ensure the integrity of the specimen.

c. Reference Laboratory shall supply any special preservatives required for specimen preservation.

d. Reference Laboratory shall notify VA Facilities of any specimen problems or discrepancies from the submitted manifest within 24 hours after shipping.

e. The Reference Laboratory shall provide routine scheduled specimen pickup at a time mutually agreed upon by the VA facilities but not less than once a day.

f. The VA Facilities laboratory manager or designee shall notify the Reference Laboratory during weekends and federal holidays, via telephone, when a pick-up courier is required.

g. The Reference Laboratory shall provide STAT (reportable within two hours or less of specimen pickup) specimen capability.

7. DELIVERY AND REPORTING

a. Billing summaries shall begin the first day of the month and include the last day of the month.

b. Tests referred to another laboratory shall be at no additional transfer charge or confirmation charge to the government.

c. Deliveries must be accompanied by a delivery ticker or sales slip that contains the following information as a minimum:

1) Vendor Name

2) Applicable contract number

3) BPA, IDIQ Number, Task order number, and Purchase Order number

4) Date of Purchase

5) Date of Shipment

6) Description of item

7) Quantity of each item

8) Unit price and extended (quantity x unit price) price for each item

d. The Reference Laboratory shall provide a quarterly and end of year report showing sample issues, facility usage, and cost savings generated during the reporting period. The report will be due 45 days after the close of each government fiscal quarter.

e. Yearly antibiogram report to be supplied.

8. PERFORMANCE MONITORING

a. At the time of contract award the Contracting Officer will appoint a Contracting Officer Representative (COR) to assist with the contract monitoring requirements. The COR or designee will monitor such items as quality of service, contractor's ability to meet TAT's, correct billing, customer service, and review of the contractor's proficiency program.

b. Contractor shall provide to the COR or designee no later than Ninety (90) days prior to the end of each contract period a proficiency report. The COR or designee shall review the proficiency results. The contractor shall maintain a minimum of 95% success rate for proficiency testing to be considered successful. Failure to achieve 95% success rate two periods in a row could be grounds for Termination for Cause.

c. The COR or designee will ensure that services performed are in accordance with all terms and conditions of the contract.

d. The delegated COR or designee will notify the Contracting Officer of any non-compliance immediately upon his/her gaining knowledge of any such situation or incident. After such communication, the COR or designee will provide a written statement to the contracting officer along with any supporting documentation regarding the performance failure noted.

e. Upon receipt of a proper invoice, the COR or designee shall certify that the services identified have been performed. Once certification has been made, the invoice will be forward through the proper billing channels and payment shall be made to the Contractor.

f. It is the intention of both parties to conduct joint reviews prior to the expiration date of the contract to determine and evaluate if services being provided are in accordance with the contract terms, payments and billings are being properly handled and to jointly determine if this agreement is satisfactory to both parties in terms of services provided and consideration being received. This review may include. but not be limited to: analyzing all billings, payments, costs, administrative issues, patient satisfaction, quality of care and other related documentation that identities that services have been received.

g. Upon conclusion of the initial contract period, and in coordination with the Contracting Officer, the using service shall provide a statement to the Contracting Officer providing a summary of contractor actions and a statement that all requirements of the contract were fulfilled as agreed. This information shall be forwarded by the COR or designee to the Contracting Officer prior to exercising any extension of this agreement (at least 60 days prior to contract expiration).

9. LICENSING AND ACCREDITATION

a. Reference Laboratory shall provide copies of all licenses, permits, accreditation and certificates required by law. Laboratory Director shall be a licensed American Board of Pathology certified pathologist or appropriately certified bio-analyst.

b. All medical facilities providing laboratory services under the contract must possess a valid state license and meet JC standards as well as CLIA requirements and standards of the College of American Pathologists (CAP).

10. PERSONNEL

a. The Reference Laboratory shall make sure employees have current and valid professional certifications before starting work under this contract.

b. The Reference Laboratory staff shall meet personnel qualifications required by Clinical Laboratory Improvement Act (CLIA) '88 Guidelines.

c. The Government’s reserves the right to request information or certification from the contractor verifying they comply with this contract requirement. If discovered the contractor is not in compliance with this requirement the contract shall be terminated for cause in accordance with clause 52.212-4.

11. HOURS OF OPERATION

a. The Boise VA is open 24 hours a day, 7 days a week, 12 months of the year and may require services during those times.

12. PATIENT INFORMATION SAFETY

a. The Reference Laboratory shall not use or disclose Protected Health Information (PHI) other than as permitted or required by the agreement or as required by law.

b. The Reference Laboratory shall use appropriate safeguards to prevent use or disclosure of the PHI other than is provided for by this agreement.

c. The Reference Laboratory shall report immediately any breach of safeguards and mitigate any harmful effects related to the use or disclosure of PHI by the Reference Laboratory or any of its agents, including sub-contractors.

13. SECURITY REQUIREMENTS

The Reference Laboratory shall be responsible for adhering to the following statements as they relate to the contract. Boise VA in coordination with their site Information Security Officer (ISO) shall monitor the work performed by contractor personnel, including sub-contractors, on a periodic basis to make sure contractor personnel are following the stated security requirements.

14. Quality Assurance Surveillance Program

SOW

Task#

Quality Monitor
Format
Calendar Days After CO Start
Acceptability Level
1
Licensures/Certificates
Copies
At initial award, and when renewed
100% Received
2
Monthly Test Summary
One electronic copy
Monthly on the 10th work day
100% Received
3
Contact Phone List
One electronic copy
At initial award, and when changes occur
100% Received
4
Laboratory User Manual
Electronic copy and one hard copy
At initial award
100% Received
5
Turn Around Time
One electronic copy
Monthly
95% meets established limits
6
Proficiency Testing
One electronic copy
90 days prior to the end of contract period
95% meets success rates
7
Antibiogram Report
One electronic copy
Annually
100% Received

Table A: VA Turn Around Times for most common orders but not inclusive of all orders

Test Ordered Name
TAT in days
Test Ordered Name
TAT in days
5-HIAA,QUANT.,24 HR
6 days
HEMOCHROMATOSIS
5 days
ACHR BINDING ABS
2 days
HLA B 27 DISEASE
4 days
ALDOSTERONE/RENIN RA
6 days
IGF-1
7 days
ALK PHOS ISOENZYME
4 days
IGG, SUBCLASSES(1-4)
3 days
ALLERGEN PROFILE FOOD
3 days
IMMUNOGLOBULIN E
4 days
ALLERGENS PANEL
3 days
INFLIXIMAB (IFX)
6 days
AMPHETAMINE (GC/MS)
3 days
JC VIRUS DNA,PCR
3 days
ANCA PANEL
2 days
LAMOTRIGINE
4 days
ANGIOTENSIN-CONVERTING
2 days
LEAD, BLOOD
2 days
ANTICARDIOLIP AB, IG
3 days
LEVETIRACETAM
4 days
ANTINUCLEAR AB
4 days
LITHIUM
3 days
BENZODIAZEPINES CONF
3 days
LUPUS ANTICOAGULANT
4 days
BETA-HYDROXYBUTYRATE
2 days
LYME, TOTAL AB
3 days
BK QUANT PCR
2 days
MANGANESE, PLASMA
5 days
CA 19-9
2 days
MEASLES/MUMPS/RUBELL
4 days
CALCIUM, 24HR URINE
2 days
METHADONE CONFIRM
3 days
CALCIUM, IONIZED
4 days
METHYLMALONIC ACID
5 days
CALCULI, URINARY
3 days
MYCOPHENOLIC ACID
3 days
CANNABINOID (GC/MS)
5 days
NON-TREPONEMAL SCR
2 days
CARBAMAZEPINE
3 days
OPIATES CONFIRMATION
3 days
CCP ANTIBODIES IGG/IGM
3 days
OSMOLALITY
2 days
CELIAC DISEASE HLA
7 days
OSMOLALITY, URINE
2 days
CERULOPLASMIN
3 days
OXYCODONE CONFIRMATION
3 days
CHROMOGRANIN A
5 days
PHENYTOIN
4 days
CMV ABS IGG/IGM
4 days
PHOSPHORUS, URINE
2 days
CMV PCR QUAL
4 days
PROGESTERONE
3 days
COPPER
4 days
PROSTATE CANCER G3
6 days
DRUG SCREEN BLOOD
3 days
PROTEIN C-FUNCTIONAL
4 days
DS- DNA ANTIBODY
3 days
PROTEIN S-FUNCTIONAL
4 days
EBV ACUTE INFECTION
3 days
QUANTIFERON
2 days
ENDOMYSIAL ANTIBODY
4 days
RETICULIN IGA AB
4 days
ERYTHROPOIETIN (EPO)
4 days
RPR
2 days
ESTRADIOL
4 days
T3 REVERSE
3 days
ESTROGENS FRACTIONAT
4 days
T3 UPTAKE, SERUM
3 days
ESTRONE, SERUM
4 days
THYROGLOBULIN ABS
4 days
ETHYL GLUCURONIDE
3 days
THYROID ANTIBODIES
4 days
ETHYL GLUCURONIDE URINE
3 days
THYROID PEROXIDASE
3 days
FACTOR V LEIDEN
4 days
THYROXINE (T4)
3 days
FECAL FAT, QUAL
3 days
TRAMADOL SCREEN, UR
3 days
FIBRINOGEN ACTIVITY
2 days
TREPONEMA PALLIDUM ABS
3 days
GIARDIA LAMBLIA AG,
2 days
TRIIODOTHYRONINE
3 days
GLIADIN IGG/IGA AB P
4 days
TRIIODOTHYRONINE,FREE
3 days
H. PYLORI STOOL AG,
4 days
T-TRANSGLUTAMINASE
3 days
H. PYLORI, IGG ABS
4 days
VITAMIN B1
3 days
HBV REAL-TIME PCR
5 days
VITAMIN B6, PLASMA
4 days
HCG,BETA SUBUNIT, QN
2 days
VITAMIN D 1,25
4 days
HCV FIBROSURE
5 days
VITAMIN E, SERUM
3 days
HEAVY METALS PROFILE
4 days
VZ VIRUS DNA, QN
3 days
HELPER T-LYMPH-CD4
3 days
Microbiology Test Name
TAT in days
CPT Code
BLOOD CULTURE, ROUTINE
5 day
87040
AEROBIC BACTERIAL CU
2 day
87070
BODY FLUID CULTURE
5 day
87070
GENITAL CULTURE
2 day
87070
SPUTUM CULTURE
2 day
87070
ANAEROBE ID/SUSCEPT
5 day
87076
AEROBE ID + SUSCEPT
2 day
87077
BETA STREP GP A CULTURE
1 day
87081
STREP B CULTURE
2 day
87081
URINE CULTURE, ROUTINE
2 day
87086
ORGANISM IDENTIFICAT
Case by case basis, 7-28 day
87107
SUSCEPTIBILITY
4 day
87184
MIC ORGANISM #1
Case by case basis, 2-28 day
87186
MIC ORGANISM #2
Case by case basis, 2-28 day
87186
MIC ORGANISM #3
Case by case basis, 2-28 day
87186
MIN INHIBITORY CONC
4 day
87186
SENSITIVITY ORGANISM
4 day
87186
GRAM STAIN
2 day
87205
VIRAL CULTURE
Case by case basis, 4-24 day
87252
VIRAL CULTURE,RAPID
4 day
87254
HSV CULTURE & TYPIING
5 day
87255
E COLI TOXIN W/RF O157
2 day
87427
INFLUENZA A&B PCR
2 day
87502
MTB NAA WITHOUT AFB
4 day
87556
CELL CT FLUID
1 day
89051
STOOL WBC
4 day
89055

CHEMISTRY FLUID PANEL

3 day 82945 ,84157 ,82042 ,83615

CELL CT SYNOVIAL
1 day
83872 ,89051 ,89060
STOOL CULTURE
6 day
87045 ,87046 ,87427
ANAEROBIC & AEROBIC
6 day
87070 ,87075
ANAEROBIC CULTURE
5 day
87075, 87205
FUNGUS CULTURE
Case by case basis, 28-42 day
87101 ,87206
OVA + PARASITE EXAM
7 day
87177 ,87209
ACID FAST SMEAR & CULTURE
51 day
87206 ,87116
CHLAMYDIA/GC AMPLIFICATION
3 day
87491 ,87591
CT/GC NAA, RECTAL
3 day
87491 ,87591

BACKGROUND INVESTIGATIONS AND SPECIAL AGREEMENT CHECKS

All Reference Laboratory employees are subject to the same level of investigation as VA employees who have access to VA sensitive information. The level of background investigation commensurate with the level of access needed to perform the work is: Low Risk. This requirement is applicable to all subcontractor personnel requiring the same access.

The Reference Laboratory shall bear the expense of obtaining background investigations. If the investigation is conducted by the Office of Personnel Management (OPM) through the VA, the Reference Laboratory shall reimburse the VA within 30 days.

VA INFORMATION SECURITY LANGUAGE

General

Contractors, contractor personnel, subcontractors, and subcontractor personnel shall be subject to the same Federal laws, regulations, standards and VA Directives and Handbooks as VA and VA personnel regarding information and information system security.

Access to VA Information and VA Information Systems

a. A contractor/subcontractor shall request logical (technical) or physical access to VA information and VA information systems for their employees, subcontractors, and affiliates only to the extent necessary to perform the services specified in the contract, agreement or task order.

b. All contractors, subcontractors, and third party servicers and associates working with VA information are subject to the same investigative requirements as those of VA appointees or employees who have access to the same types of information. The level and process of background security investigations for contractors must be in accordance with VA Directive and Handbook 0710, Personnel Suitability and Security Program. The Office for Operations, Security, and Preparedness is responsible for these policies and procedures.

c. Contract personnel who require access to national security programs must have a valid security clearance. National Industrial Security Program (NISP) was established by executive Order 12829 to ensure that cleared US defense industry contract personnel safeguard the classified information in their possession while performing work on contracts, programs, bids, or research and development efforts. The Department of Veteran Affairs does not have a Memorandum of Agreement with Defense Security Services (DSS). Verification of a Security Clearance must be processed through the Special Security Officer located in the Planning and National Security Service within the Office of Operations, Security, and Preparedness.

d. Custom software development and outsourced operations must be located in the US to the maximum extent practical. If such services are proposed to be performed abroad and are not disallowed by other VA policy or mandates, the contractor/subcontractor must state where all non-US services are provided and detail a security plan, deemed to be acceptable to VA, specifically to address mitigation of the resulting problems of communication, control, data protection, and so forth. Location within the US may be an evaluation factor.

e. The contractor or subcontractor must notify the Contracting Officer immediately when an employee working on a VA system or with access to VA information is reassigned or leaves the contractor or subcontractor's employ. The Contracting Officer must also be notified immediately by the contractor or subcontractor prior to an unfriendly termination.

Custody of VA Information

a. Information made available to the contractor or subcontractor by VA for the performance or administration of the contract shall be used only for the purposes and shall not be used in any other way without the written agreement of the VA. This clause expressly limits the contractor/subcontractor's rights to use data as described in Rights of Data – General, FAR 52.227-14(d) (1).

b. VA information should not be co-mingled, if possible, with any other data on the contractor/subcontractor's information systems or media storage systems in order to ensure VA requirements related to data protection and media sanitization can be met. If co-mingling must be allowed to meet the requirements of the business need, the contractor must ensure that VA's information is returned to the VA or destroyed in accordance with VA's sanitization requirements. VA reserves the right to conduct onsite inspections of contractor and subcontractor IT resources to ensure data security controls, separation of data and job duties, and destruction/media sanitization procedures are in compliance with VA directive requirements.

c. Prior to termination or completion of this contract, contractor/subcontractor must not destroy information received from VA, or gathered / created by the contractor in the course of performing the contract without prior written approval by the VA. Any data destruction done on behalf of VA by a Contractor/subcontractor must be done in accordance with VA Directive 6300, Records and Information Management and its Handbook 6300.1, Electronic Media Sanitization. Self0-certification by the contractor that the data destruction requirements above have been met must be sent to the VA Contracting Officer within 30 days of termination of the contract.

d. The contractor/subcontractor must receive, gather, store, back up, maintain, use, disclose and dispose of VA information only in compliance with the terms of the contract and applicable Federal and VA information confidentiality and security laws, regulations and policies. If Federal or VA information confidentiality and security laws, regulations and policies become applicable to the VA information or information systems after execution of the contract, or if NIST issues or updates applicable to FIPS or Special Publications (SP) after execution of this contract, the parties agree to negotiate in good faith to implement the information confidentiality and security laws, regulations and policies in this contract.

e. The contractor/subcontractor shall not make copies of VA information except as authorized and necessary to perform the terms of the agreement or to preserve electronic information stored on contractor/subcontractor electronic storage media for restoration in case any electronic equipment or date used by the contractor/subcontractor needs to be restored in an operating state. If copies are made for restoration purposes, after the restoration is complete, the copies must be appropriately destroyed.

f. If VA determines that the contractor has violated any of the information confidentiality, privacy, and security provisions of the contract, it shall be sufficient grounds for VA to withhold payment to the contractor or third party or terminate the contract for default or terminate for cause under FAR Part 12.

g. If a VHA contract is terminated for cause, the associated BAA must also be terminated an appropriate actions taken in accordance with VHA Handbook 1600.01, Business Associate Agreements. Absent an agreement to use or disclose protected health information, there is no business relationship.

h. The contractor/subcontractor must store, transport, or transmit VA sensitive information in an encrypted form, using VA-approved encryption tools that are, at a minimum, FIPS 140-2 validated.

i. The contractor/subcontractor's firewall and Web services security controls, if applicable, shall meet or exceed VA's minimum requirements. VA Configuration Guidelines are available upon request.

j. Except for uses and disclosures of VA information authorized by this contract for performance of the contract, the contractor/subcontractor may use and disclose VA information only in two other situations:

(i) in response to a qualifying order of a court of competent jurisdiction, or (ii) with VA's prior written approval. The contractor/subcontractor must refer all requests for, demands for production of, or inquiries about, VA information and information systems to the VA contracting officer for response.

k. Notwithstanding the provision above, the contractor/subcontractor shall not release VA records protected by Title 38 U.S.C. 5705, confidentiality of medical quality assurance records and/or Title 38 U.S.C. 7332, confidentiality of certain health records pertaining to drug addiction, sickle cell anemia, alcoholism, or alcohol abuse, or infection with human immunodeficiency virus. If the contractor/subcontractor is in receipt of a court order or other requests for the above mentioned information, the contractor/subcontractor shall immediately refer such court orders or other requests to the VA Contracting Officer for response.

l. For service that involves the storage, generating, transmitting, or exchanging of VA sensitive information but does not require C&A or an MOU-ISA for system interconnection, the contractor/subcontractor must complete a Contractor Security Control Assessment (CSCA) on a yearly basis and provide it to the COTR.

Security Incident Investigation

a. The term "security incident" means an event that has, or could have, resulted in unauthorized access to, loss or damage to VA assets, or sensitive information, or an action that breaches VA security procedures. The contractor/subcontractor shall immediately notify the Contracting Officer and the COTR and simultaneously, the designated ISO and Privacy Officer for the contract of any known or suspected security/privacy incidents, or any unauthorized disclosure of sensitive information, including that contained in system(s) to which the contractor/subcontractor has access.

b. To the extent known by the contractor/subcontractor, the notice to VA shall identify the information involved, the circumstances surrounding the incident (including to whom, how, when, and where the VA information or assets were placed at risk or compromised), and any other information that the contractor/subcontractor considers relevant.

c. With respect to unsecured protected health information, the business associate is deemed to have discovered a date breach when the business associate knew or should have known of a breach of such information. Upon discovery, the business associate must notify the covered entity of the breach. Notifications need to be made in accordance with the executed business associate agreement.

d. In instances of theft, break-in, or other criminal activity, the contractor/subcontractor must concurrently report the incident to the appropriate law enforcement entity (or entities) of jurisdiction, including the VA OIG and Security and Law Enforcement. The Contractor, its employees, and its subcontractors and their employees shall cooperate with VA and any law enforcement authority responsible for the investigation and prosecution of any possible criminal law violation(s) associated with any incident. The contractor/subcontractor shall cooperate with VA in any civil litigation to recover VA information, obtain monetary or other compensation from a third party for damages arising from any incident, or obtain injunctive relief against any third party arising from, or related to, the incident.

Liquidated Damages for Data Breach

a. Consistent with the requirements of 38U.S.C. 5725, a contract may require access to sensitive personal information. If so, the contractor is liable to VA for liquidated damages in the event of a data breach or privacy incident involving any SPI the contractor/subcontractor processes or maintains under the contract.

b. The contractor/subcontractor shall provide notice to VA of a "security incident" as set forth in the Security Incident Investigation section above. Upon such notification, VA must secure from a non- Department entity of the VA Office of Inspector General an independent risk analysis of the data breach to determine the level of risk associated with the date breach for the potential misuse of any sensitive personal information involved in the data breach. The term "data breach" means the loss, theft, or other unauthorized access, or any access other than that incidental to the scope of employment, to data containing sensitive personal information, in electronic or printed form, that results in the potential compromise of the confidentiality or integrity of the data. Contractor shall fully cooperate with the entity performing the risk analysis. Failure to cooperate may be deemed a material breach and grounds for contract termination.

c. Each risk analysis shall address all relevant information concerning the data breach, including the following:

1. Nature of event (loss, theft, unauthorized access);

2. Description of the event, including:

a. Date of occurrence

b. Date elements involved, including any PII, such as full name, social security number, date of birth, home address, account number, disability code:

3. Number of individuals affected or potentially affected;

4. Names of individuals or groups affected or potentially affected;

5. Ease of logical date access to the lost, stolen, or improperly accessed data in light of the degree of protection for the data, e.g. unencrypted, plain text;

6. Amount of time the data has been out of VA control;

7. The likelihood that the sensitive personal information will or has been compromised (made accessible to and usable by unauthorized persons);

8. Known misuses of date containing sensitive personal information, if any;

9. Assessment of the potential harm to the affected individuals;

10. Data breach analysis as outlined in 6500.2 Handbook, Management of Security and Privacy Incidents, as appropriate; and

11. Whether credit protection services may assist record subjects in avoiding or mitigating the results of identity theft based on the sensitive personal information that may have been compromised.

d. Based on the determinations of the independent risk analysis, the contractor shall be responsible for paying to the VA liquidated damages of $37.50 per affected individual to cover the cost of providing credit protection services to affected individuals consisting of the following:

1. Notification;

2. One year of credit report monitoring services consisting of automatic daily monitoring of at least 3 relevant credit bureau reports;

3. Data breach analysis;

4. Fraud resolution services, including writing dispute letters, initiating fraud alerts and credit freezes, to assist affected individuals to bring matters to resolution;

5. One year of identity theft insurance with $20,000 coverage at $0 deductible; and

6. Necessary legal expenses the subjects may incur to repair falsified or damaged credit records, histories, or financial affairs.

Security Controls Compliance Testing

On a periodic basis, VA, including the Office of Inspector General, reserves the right to evaluate any or all of the security controls and privacy practices implemented by the contractor under the clauses contained within the contract. Within 10 working day notice, at the request of the government, the contractor must fully cooperate and assist in a government sponsored security controls assessment at each location wherein VA information is processed or stored, or information systems are developed operated, maintained, or used on behalf of VA, including those initiated by the Office of Inspector General. The government may conduct a security control assessment on shorter notice (to include unannounced assessments) as determined by VA in the event of a security incident or at any other time.

Training

a. All contractor employees and subcontractor employees requiring access to VA information and VA information systems shall complete the following before being granted access to VA information and its systems:

1. Sign and acknowledge (either manually or electronically) understanding of and responsibilities for compliance with the Contractor Rules of Behavior, Appendix E relating to access to VA information and information systems;

2. Successfully complete the VA Cyber Security Awareness and Rules of Behavior training and annually compete the required security training;

3. Successfully complete the appropriate VA privacy training and annually complete required privacy training; and

4. Successfully complete any additional cyber security or privacy training, as required for VA personnel with equivalent information system access.

b. The contractor shall provide to the Contracting Officer and/or the COTR a copy of training certificates and certification of signing the Contractor Rules of Behavior for each applicable employee within 1 week of the initiation of the contract and annually thereafter, as required.

c. Failure to complete the mandatory annual training and sign the Rules of Behavior annually, within the timeframe required, is grounds for suspension or termination of all physical or electronic access privileges and removal from work on the contract until such time as the training and documents are complete.

Table B Reference Test Menu Required as well as average annual Boise VA Laboratory Send-Out Volume

TEST DESCRIPTION

CPT CODES

TOTAL

1 year volume

Drug Monitoring
80307
1075
QUANTIFERON(R)-TB GOLD, 1
86480
718
RPR (MONITOR) WITH REF
86592
693
PEP W/TOTAL, RFX IFE
84155, 84165
609
C.TRACHO/N.GONO RNA, TMA
87491, 87591
530
ANA SCREEN, IFA, RFLX
86038
432
MMR(IGG)PNL,IMMUNE STATUS
86735, 86762, 86765
421
VZV IGG ABS
86787
360
DRUG TEST, GENERAL TOX
CKWEB
329
METHYLMALONIC ACID
83921
271
IMMUNOFIXATION, SERUM
86334
267
T3, FREE
84481
236
Opiate Confirmation, Urine
80361
229
TACROLIMUS HIGH SENSITIV
80197
214
KAPPA/LAMBDA LHT CHN FREE
83520 (2)
212
HOMOCYSTEINE
83090
201
CCP IGG ANTIBODIES
86200
163
SYPHILIS AB CASCADING
86780
158
TISSUE TRANSGLUT IGA
83516
153
LYMPHOCYTE SUBSET PNL2
86355, 86359, 86360
148
ESTRADIOL
82670
140

Amphetamine Confirmation Urine

80324

REFLEX ANA, TIT AND PA
86039
136
VIT B1 (THIAMINE), BLD
84425
135
HIV-1 QUANTITATION RT PCR
87536
132
VITAMIN D, 1,25-OH
82652
121

Benzodiazepine, Confirmation Urine

80346

TRAMADOL, SCREEN W/ CONF.
80307
102
ALPHA-1-ANTITRYPSIN QUAN
82103
98
CULT, FUNGUS, MISC SOURCE
87102
97
ERYTHROPOIETIN
82668
95
COPPER
82525
89
CA 19-9
86301
86
IMMUNOGLOBULIN E
82785
79
H PYLORI AG STOOL
87338
77
REFLX TRAMADOL METAB, QN
80373
77
ALDOSTERONE/PL RENIN A
82088, 84244
76
STONE ANALYSIS WITH IMAGE
82365
76
CHROM, HEMATOLOGIC
88237, 88264
72
Oxycodone, Confirmation Urine
80365
71
CARDIOLIPIN AB A,G,M
86147 (3)
64
LEU & LYM 22 MARKERS
88184, 88185 (21), 88189
62
PROTEIN ELECTRO EVAL
82570, 84156, 84166
62
VZV IGG & IGM ABS
86787 (2)
60
THYROID CANCER MONITOR
86800
60
FOLATE, RBC
82747
59
PROT.ELEC,RANDURN W
82570, 84156, 84166
59
BCR-ABL1 GENE REARRANG
81206
58
METHYLMALONIC ACID, GC
82570, 83921
57
PROGESTERONE
84144
56
DHEA, UNCONJUGATED
82626
56
THYROGLOBULIN
84432
56
REFLEX P210 BCR-ABL1
81206
56
ACTIN (SMOOTH MUSCLE)
83516
55
(AAT) QN AND PHENOTYPE
82103, 82104
55
HBV B DNA QUANT REAL-TIME
87517
54
BETA-2-GLY IGG IGM IGA
86146 (3)
54
ANCA SCREEN W/REFLX T
86021
54
T3, TOTAL
84480
53
ZINC
84630
52
PTHRP
83519
52
FRUCTOSAMINE
82985
49
CERULOPLASMIN
82390
47
THYROID PEROX AND THY AB
86376, 86800
47
CYCLOSPORINE A, TROUGH
80158
46
HEAVY METALS PANEL (VENO)
82175, 83655, 83825
45
CALPROTECTIN, STOOL
83993
45
INSULIN
83525
43
LUPUS ANTICOAGULANT EVAL
85613, 85730
43
HSV 1 & 2 IGG ABS
86695, 86696
41
HEREDITARY HEMOCHROM
81256
41
SJOGREN'S ABS (SS-A,SS
86235 (2)
40
YEAST IDENTIFICATION 1
87106
40
IMMUNOFIXATION, SERUM
86334
39
LEVETIRACETAM
80177
38
5-HIAA 24HR URN W/CREA
82570, 83497
37
FACTOR V (LEIDEN) MUT
81241
36
JAK2 V617F CASCADINGRF
81219, 81270, 81279, 81339, 81479
36
DNA (DS) ANTIBODY
86225
34
HLA-B27 ANTIGEN
86812
34
VIT B6, PLASMA
84207
34
MITOCHONDRIAL M2 AB IGG
83520
34
ENDOMYSIAL AB SCRN RFLX
86255
34
CMV DNA QN RT PCR
87497
32
5' NUCLEOTIDASE
83915
30
SCL-70 ANTIBODY
86235
30

URORISK(R) DIAGNOSTIC P

82340, 82507, 82570, 83735, 83945, 83986, 84105, 84133, 84300, 84392, 84560

HSV 1/2 AB IFA W/RFX TITR
86695, 86696
29
PROTH (FACT II) 20210G
81240
28
C-PEPTIDE
84681
27
HEMOGLOBIN A1C
83036
27
LYME AB W/RFX IGG/IGM
86618
27
CHLAM TRAC/NEIS.THROAT
87491, 87591
27
FISH,MDS/MYELOID PNL
88271 (6), 88275 (3)
26
CHROMOGRANIN A
86316
26
REFLEX P190 BCR-ABL1
81207
26
ACTH, PLASMA
82024
25
CA 125
86304
25
CMV IGG/M ABS
86644, 86645
25
IGG TOTAL W/SUBCLASS 123
82784, 82787 (4)
24
HERPES SIMPLEX VIRUS,
87529 (2)
24
GLUTAMIC ACID DECARBOX
86341
23
NICOTINE&COTININE
80323
23

WILD CODE AMBIENT

HEPATITIS BE PANEL
86707, 87350
22
BK VIRUS DNA, QUANTITA
87799
22
CHLAM TRAC/NEIS.RECTAL
87491, 87591
22
METANEPH, FREE, PLASMA
83835
22
TPMT ACTIVITY
82657
21
TRAB (TSH RECEPTOR AB)
83520
21
PROTEIN C & S ACTIVITY
85303, 85306
21

WILD CODE FROZEN

SM AND SM/RNP ANTI
86235 (2)
20
CORTISOL FREE, 24HR UR
82530
20
LKM-1 AB IGG
86376
18
MYCOPL PNEUM DNA, QL
87581
18
ALDOLASE
82085
17
VITAMIN E (TOCOPHEROL)
84446
17
FECAL FAT, QUALITATIVE
82705
17
LEGIONELLA DNA,QLRTPCR
87541, 87798
17
LAMOTRIGINE
80175
17
BETA-HYDROXYBUTYRATE
82010
17
FREE KAPPA/LAMBDA W/KL
83883 (2)
17
LEAD (VENOUS)
83655
16
VITAMIN A (RETINOL)
84590
16
**STONE ANALYSIS
82365
16
CYTOMEGALOVIRUS DNA QL
87496
16
INTERLEUKIN-6 (IL-6)
83520
16
MYASTHENIA GRAVIS PNL2
83519 (3)
16
REFLEX DRVVT CONFIRM
85597
16
REFLEX RPR TITER
86593
16
CHLAMYDOPHILA PNEU DNA
87486
16
ALK PHOSPHATASE ISOENZ
84075, 84080
15
CA 15-3
86300
15
GLIADIN AB (IGG, IGA)
83516 (2)
15
CRYOGLOBULIN SCREEN WITHL
82595
15
REFLEX MUSK AB TEST
83519
15
EBV AB PANEL
86664, 86665 (2)
14
MYELOPEROXIDASE AB
86021
14
LIPOPROTEIN (A)
83695
14
SIROLIMUS LC/MS/MS
80195
14
BILL ONLY PNEUMOCYSTI
87015, 87281
14
**PM ALCOHOL METAB
80321
14
IGF-I, LC/MS
84305
14
ANTITHROMBIN III ANT
85301
13
RESPIRATORY VIRUS SCRE
87300
13
METANEP, FRAC, 24HR UR
83835
13
CENTROMERE B AB
86235
13
MULTIPLE SCLEROSIS PAN
82040, 82042, 82784 (2), 83916
13
T3 REVERSE, LC/MS/MS
84482
13
CYSTATIN C WITH EGFR
82610
13
FISH-B-CELL CLL PNL
88271 (6), 88275 (3)
12
FISH, MYELOMA W/REFLEXES
88271 (11), 88275 (5)
12
MONOCLONAL GAMMOPATH U
86335
12
HETEROPHILE, MONO SCRN
86308
12
ANGIOTENSIN CONVERTING EN
82164
12
BETA-2-MICROGLOBULIN, SER
82232
12
FUNGITELL(R)(1-3)BD-GL
87449
12
PROTEINASE-3 ANTIBODY
86021
12
EPSTEIN-BARR VIRUS
87798
12
KAPPA/LAMBDA CHAINS UR
83883 (2)
12
CATECHOLAMINES, FRACTI
82384, 82570
12
RFLX HEXAGONAL PHASE CONF
85598
12
BILL ONLY LEUK/LYMP EV
88184, 88185 (21), 88189
12
RNA POLYMERASE III
83516
12
LEU & LYM 25 MARKERS
88184, 88185 (24), 88189
11
ANTITHROMBIN III ACT
85300
11
G-6-PD
82955
11
INFLIXIMAB LEV/AB, IBD
80230, 83520
11
VIT B2 (RIBOFLAVIN), PLA
84252
11
Methadone, Confirmation Urine
80358
11
COCCIDIODIDES AB
86635 (2)
11
LEUK&LYMP EVAL, 26 MARKR
88184, 88185 (25), 88189
10
HERPES SIMPLEX W/ REFL
87255
10
SELENIUM, BLOOD
84255
10
CLOZAPINE
80159
10
P16,IHC W/O INTERP
88342
9
PARVOVIRUS B19 ANTIBOD
86747 (2)
9
TRYPTASE
83520
9
MOLD IDENTIFICATION 1
87107
9
MYOSITIS SPEC 11 ABS PAN
84182 (6), 86235 (5)
9
VDRL, CSF
86592
9
FISH, HIGH-GRADE LYMPHOMA
88271 (6), 88275 (3)
8
ANTI-STREPTOLYSIN O AB
86060
8
HEP-INDUCED PLT AB
86022
8
PROTEIN C ANTIGEN
85302
8
PROTEIN S AG, TOTAL
85305
8
PANCREATIC ELASTASE 1
83520
8
DIPHTHERIA & TETANUS
86648, 86774
8
HEMOGLOBINOPATHY EVALU
83020, 85014, 85018, 85041
8
MYELIN ASSOC GYLCOPROT
83520
8
AMH, FEMALE
83520
8
Cannabinoids SCREEN W/R
80307
8
RFX IMMUNOFIXATION,URN
86335
8
REFLEX RPR SCREEN
86592
8
EBV,ISH W/O INTERP
88365TC
7
DHEA SULFATE, IMMUNOASSAY
82627
7
ESTROGEN, TOTAL, SERUM
82672
7
HEMOGLOBIN,FREE,PLASMA
83051
7
COMPLEMENT, TOTAL (CH50
86162
7
THYROID PEROXIDASE AUTOAB
86376
7
STOOL ROUTINE CULTURE
CKWEB
7
S CEREVISIAE IGG & IGA
86671 (2)
7
SUSCEP, YEAST, COMP PANEL
87186
7
STRONGYLOIDES ANTIBODY
86682
7
ESTROGENS, FRAC,LC/MS
82671
7
YEAST IDENTIFICATION 2
87106
7

STATEMENT OF WORK (SOW) for Reference Laboratory Services Boise VAMC Laboratory

THROMBIN CLOTTING TIME
85670
7
JO-1 ANTIBODY
86235
7

Buprenorphine, Confirmation Urine

80348

OPIATE W/CONF PNL BV
80307
7
RFLX MARIJUANA MTBLT QUAN
80349
7
HYPERSENSITIVITY PNEUMON
CKWEB
7
CYCLIN D1,IHC W/O INTERP
88342
6
CD34,IHC W/O INTERP
88342
6
HER-2,IHC W/RFL FISH
88360
6
MSI, HNPCC
81301
6
GLOMERULAR BASEMENT
83520
6
THYROGLOBULIN ANTIBODIES
86800
6
GASTRIN
82941
6
HISTOPLASMA AB, COMP F
86698 (2)
6
CK CREATINE KIN ISOENZ
82550, 82552
6
CHROMIUM, BLOOD
82495
6
FOOD ALLERGY PROFILE
86003 (15)
6
STREP PNEU IGG AB 23
86317 (23)
6
OLANZAPINE
80299
6
REFLEX RPR TITER
86593
6
PORPHYRINS, TOTAL PLA
82542
6
KAPPA/LAMBDA,ISHW/O INTRP
88365TC (2)
5
T-CELL CLONALITY PNL
81340, 81342, 84999
5
LUNG CA (NSCLC),ROS1,FISH
88271 (2), 88274
5
COLD HEMAGGLUTININS
86157
5
OVA & PARASIT SMEAR
87177, 87209
5
PROINSULIN
84206
5
VITAMIN C
82180
5
SUSCEPTIBILITY, AEROBI
87186
5
COLLAGEN TYPE I
82523
5
INSULIN AUTOANTIBODY
86337
5
ISLET CELL AB SCRN W/R
86341
5
FOOD SPEC. IGG ALL PNL 2
86001 (13)
5
REFLEX DRVVT 1:1 MIX
85613
5
Barbiturates, Confirmation Urine
80345
5
HSV 1 IGM TITER
86695
5
HSV 2 IGM TITER
86696
5
PAX-5, IHC W/O INTERP
88341
4
EGFR MUTATION
81235
4
MYD88, MUTATION ANALYSIS
81305
4
JAK2 V617F CASCADING REFL
81270
4
PDL1 LUNG IHC
88360
4
PD-L1, IHC W/ INTERP
88360
4
HER-2, FISH, PARAFFIN BL
88377
4

SPECIAL TEST-PHENOPATH

C1 ESTERASE INH, FUNCT
86161
4
CAROTENE
82380
4
LYSOZYME (MURAMIDASE)
85549
4
T4 (THYROXINE), TOTAL
84436
4
HEPATITIS D AB, TOTAL
86692
4
APOLIPOPROT EVALUATION
82172 (2)
4
HEAVY METALS PANEL,
82175, 82570, 83655, 83825
4
MAGNESIUM URINE 24H
83735
4
HSV VIRUS/VAR ZOSTER
87254 (2)
4
NOROVIRUS RNA Q RT-PCR
87798
4
CALCITONIN
82308 (2)
4
ELECTROLYTES, FECES
82438, 84302, 84311
4
COBALT, BLOOD
83018
4
OXCARBAZEPINE METABOLITE
80183
4
HU AB SCREEN W/REFLEX
86255
4
GIARDIA/CRYPTOSP AG
CKWEB
4
REFLEX HSV TYPE 2
87140
4
NICOTINE & COTININE UR
80323
4
TRICHOMONAS VAGI, MALES
87661
4
ASPERGILLUS AB PANEL,C
86606 (4)
4
RFX ATYPICAL P-ANCA TI
86021
4
THYROGLOBULIN,LC/MS/MS
84432
4
IMMUNE COMPLEX BY C1Q
86332
4
HISTONE ANTIBODIES
83516
4
CD20,IHC W/O INTERP
88342
3

VWF AG,IHC W/O INTERP

KI-67,IHC W/O INTERP
88360
3
CD138,IHC W/O INTERP
88342
3
FISH,AML,CBFB,MYH11,INV16
88271 (2), 88275
3
FISH,MANTLE CELL LYMPHOMA
88271 (2), 88275
3
BRAF MUTATION ANALYSIS
81210
3
BCL-6, IHC W/O INTERP
88341
3
LUNG CA (NSCLC),ALK,FISH
88271 (2), 88274
3
PD-L1 LUNG HIVOLUMAB IHC
88342
3

SPECIAL TEST-QUEST CHY

PROTEIN C RESIST ACTIV
85307
3
STRIATED MUSCLE W/RFLX
86255
3
CATECHOLAMINES, FRACTI
82384
3
MYOGLOBIN, URINE
83874
3
VISCOSITY, SERUM
85810
3
VMA, 24-HR URN (W/O C)
84585
3
PHENYTOIN FREE
80186
3
TOXOPLASMA IGG & IGM
86777, 86778
3
OXALIC A 24HR U WO/C
83945
3
CHROMOSOM ANALYSIS BLD
CKWEB
3
GASTRIC PARIETAL CELL
83516
3
HLA-DR/DQ LOW R. TYPIN
81375
3
LACOSAMIDE
80235
3
TSI (THYROID STIM IMM)
84445
3
BACTERIAL ID, AEROBIC
87077
3
HEAVY METALS 24H URINE
82175, 83655, 83825
3
PORPHYRINS,FRAC,QN,RAN
84120
3
CULTURE, FUNGUS, BLOOD
87103
3
VORICONAZOLE
80285
3
ALPHA-1-ANTITRYPSIN
82103
3
IGD, SERUM
82784
3
PORPHOBLN RANDOM UR
84110
3
DELTA-AMINOLEVULINIC
82135
3
VZV DNA, QUANT R-T PCR
87799
3
PHENOBARBITAL
80184
3
ER/PR, PARAFFIN BLOCK
88360 (2)
2
BCL-2,IHC W/O INTERP
88341
2
CD3,IHC W/O INTERP
88342
2
CD30,IHC W/O INTERP
88342
2
CD5,IHC W/O INTERP
88342
2
CD57,IHC W/O INTERP
88342
2
CD23,IHC W/O INTERP
88342
2
CD56,IHC W/O INTERP
88342
2
TTF-1,IHC W/O INTERP
88342
2
PAP,IHC W/O INTERP
88342
2
PSA,IHC W/O INTERP
88341
2
FISH,MALT REA18Q21 W/RFL
88271 (2), 88275
2
HEPPAR 1, IHC W/O INTERP
88341
2
MUM1,IHC W/O INTERP
88342
2
LEU & LYM 23 MARKERS
88184, 88185 (22), 88189
2
P53,IHC W/O INTERP
88342
2
ALK 1,IHC W/O INTERP
88341
2
LEUK&LYMP EVAL, 27 MARKR
88184, 88185 (26), 88189
2
PD-L1 NON-LUNG
88360
2
LEUKOVANTAGE(TM) (AML)
81450
2
LEUKOVANTAGE(TM),(MDS)
81450
2
FISH,MPN (EOSINOPHILIA)
88271 (7), 88275 (3)
2
LYNCHSYND TUMR,IHC INTERP
88342, 88341 (x3)
2
FISH, MYELOMA, IGH PANEL
88271 (8), 88275 (4)
2

SPECIAL TEST-ARUP

C1 ESTERASE INHIB,PROTEIN
86160
2
GROWTH HORMONE
83003
2
MERCURY, BLOOD
83825
2
ETHYLENE GLYCOL
82693
2
RUBELLA ANTIBODY (IGM)
86762
2
CITRIC ACID, 24H UA
82507, 82570
2
ADRENAL AB W/RFX TO TITER
86255
2
PORPHOBLN RANDOM URINE
84110
2
LYME DIS (IGG,IGM)
86617 (2)
2
PROTEIN S ANTIG, FREE
85306
2
MYCOPHEN ACID LS/MS/MS
80180
2
CRYPTO AG/SCREEN/REF
86403
2
ASPERGILLUS ANTIG, SER
87449
2
HIV-1 INTEGRASE GENOTY
87906
2
ADA, PLEURAL FLUID
84311
2
HLA-B5701 TYPING
81381
2
SUC,ANTIMIC,A.BAC,MIC
87186
2
HIV-1 GENOTYPE
CKWEB
2
H INFLUENZAE B IGG ABS
86684
2
GANGLIOSIDE (IGG,IGM)
83520 (2)
2
GASTROINTESTINAL PAT
87506
2
PORPHOBILINOGEN,RNDM
84110
2
CULT, FUNGUS,SKIN,HAIR,NA
87101
2
REFLEX HSV TYPE 1
87140
2
MANNAN BINDING LECTIN
86161
2
ANTI SUSC PANEL, ANA
87181 (6)
2
CARDIO IQ(R) APOE GENO
81401
2
VITAMIN B3
84591
2
HISTOPLASMA GALAC AG,U
87385
2
HIV-1 RNA, QN R-T W/RF
87536
2
FGF 23
83520
2
PARANEOPLASTIC AB EVAL
83519 (5), 86255 (10)
2
PNH WITH FLAIR
CKWEB
2
CARDIO IQ(R) LP-PLA2
83698
2
URIC ACID UR
84560
2
RFX TREPONEMA PALLIDUM
86780
2
HEPATITIS E AB (IGM)
86790
2
CD117,IHC W/O INTERP
88342
1
CD15,IHC W/O INTERP
88342
1
S-100,MONO,IHC W/O INTERP
88341
1
CD79A,IHC W/O INTERP
88342
1
CD10,IHC W/O INTERP
88342
1
TDT, IHC W/O INTERP
88342
1
CD31,IHC W/O INTERP
88342
1
CD61,IHC W/O INTERP
88342
1
CD99,IHC W/O INTERP
88342
1
CYTOKER 7,IHC W/O INTERP
88342
1
CYTOKER 8/18,W/O INTERP
88342
1
CYTOKER 19,W/O INTERP
88342
1
GRANZYME-B,IHC W/O INTERP
88342
1
WT1,IHC W/O INTERP
88342
1
SYNAPTOPHYSIN,W/O INTERP
88342
1
CALRETININ,IHC W/O INTERP
88342
1
CHROMOGRANIN,IHC W/O INT
88342
1
MOC-31,IHC W/O INTERP
88341
1

CMV,IHC W/O INTERP

CEA POLY, IHC W/O INTERP
88342
1
HHV-8,IHC W/O INTERP
88342
1
NSE, IHC W/O INTERP
88341
1
CMV,IHC W/ INTERP
88342
1
FISH,CML/ALL,BCR/ABL TRAN
88271 (2), 88275
1
FISH,AML,AML1/ETO T(8,21)
88271 (2), 88275
1
FISH, AML M3, PML/RARA, T
88271 (2), 88275
1
FISH, FOLLICULAR LYMPHOMA
88271 (2), 88275
1
EBV,ISH W/INTERP
88365
1
AAT, IHC W/O INTERP
88341
1
PAN-CYTOKERATIN W/O INT
88342
1
TIA-1, IHC W/O INTERP
88342
1
FLT3 ITD AND TKD MUTATION
0023U
1

MELANOMA,BRAF V600

MUTATN

81210

BCR-ABL1,QN PCR
81206
1
FISH, MECOM, 3Q26.2
88271 (2), 88275
1
B-CELL CLONALITY, PCR
81261, 81264, 84999
1
PD-L1 BLADDER
88360
1
COX-2, IHC W/O INTERP
88342
1
P190 BCR-ABL1
81207
1
LUNG CANCER MUTATION PNL
81235, 81275, 81276, 88271 (2), 88274
1
DNASE-B ANTIBODY
86215
1
MYOCARDIAL AB W/RFLX
86255
1
NORTRIPTYLINE
80335
1
CADMIUM, BLOOD
82300
1
COPPER, 24-HOUR URINE
82525
1
CRYOFIBRINOGEN
82585
1
DESPIRAMINE
80335
1
INTRINSIC FACTOR BLOCK
86340
1
ALCOHOL, METHYL
80320
1
TREPONEMA PALLIDUM AB
86780
1
MYOGLOBIN, SERUM
83874
1
VASOACTIVE INTEST PO
84586
1
OSMOLALITY, FECES
84999
1
COMPLEMENT COMP. C1Q
86160
1
RHEUMATOID FACTOR
86431
1
CYTOMEGALOVIRUS, CON
87252, 87254
1
HERPES SIMPLEX VIRUS
87255
1
VALPROIC, ACID FREE
80165
1
RECOMBX(R) AMPH AUTOAB
83520
1
SELENIUM
84255
1
BETA-2-MICROGLOBULN URINE
82232
1
MAGNESIUM, RAND UR
82570, 83735
1
LYMPHOCYTE SUBSET PANE
86355, 86357, 86359, 86360
1
VOLATILES
80320
1
NT-PROBNP
83880
1
URIC ACID URN 24HR W/O CR
84560
1
MODIFIED ACID FAST STA
87206
1
ADAMTS13 ACT W/RFX INH
85397
1
VIRAL RESP RAPID CULT
87254
1
ENTEROVIRUS RNA,QL R-T
87498
1
HLA TYPING FOR CELIAC
81376 (2), 81382 (2)
1
PRPHYRNS,FRAC,QT,UR
84110, 84120
1
FISH, IGH/CCND, T(11;1
CKWEB
1
MTHFR, DNA MUT. ANALYS
81291
1
DRUG ABUSE SCREEN, SER
80307
1
CA 27.29
86300
1
SEROTONIN, SERUM
84260
1
TOPIRAMATE
80201
1
VZV DNA, QUAL R-T PCR
87798
1
VGCC TYPE P/Q AB
83519
1
MYCO PNEUMO IGG/M ABS
86738 (2)
1
HERPESVIRUS 6 ABS (IGM)
86790
1
MEASLES ANTIBODY (IGM)
86765
1
ENTAMOEBA HISTOLYTICA
86753
1
HERPESVIRUS 6 AB (IGG)
86790
1
TOXOCARA AB (IGG), SER
86682
1
ESTRIOL, SERUM
82677
1
ADALIMUMAB LEV/AB, IBD
80145, 83520
1
MUMPS VIRUS AB (IGM)
86735
1
WEST NILE AB IGG/IGM
86788, 86789
1
FOOD/TREE ALG PNL W/RFLX
86003 (17)
1
Q FEVER W/REFL TITERS
86638 (4)
1
EPIDERMAL AB W/ REFLEX
86255 (2)
1
BORDETELLA PERTU IGG
86615
1
TRYPSIN
83519
1
HMGCR AB (IGG)
83520
1
ADENOSINE DEAMINASERBC
84311
1
SARS COV 2 IGG
86769
1
VITAMIN B1 (THIAMINE)
84425
1
T-CELL RECEPTOR (TCR)
81342, 84999
1
SOLU TRANSFERRIN RECEPTOR
84238
1
ANAEROBIC MIC 1
87181 (6)
1
VON WILLEBRAND PANEL
85240, 85245, 85246, 85730
1
CLOSTRIDIUM DIFFICILE
87324, 87449
1
ANAEROBIC BACTERIA ID
87076
1
MOLD IDENTIFICATION 2
87107
1
CALR MUTATION ANALYSIS
81219
1
BUPRENOPHONE&METABOLITES
80348
1
AQUAPORIN-4 ANTIBODY
86255
1
DRUG MONITORING ANTIDE
80307
1
ANTI-CN-1A (NT5C1A) IB
83520
1
POLIOVRUS AB NUTRALIZA
86382 (2)
1
PLT AB SCREEN IND
86022 (5)
1
RFX P-ANCA TITER
86021
1
RFX C-ANCA TITER
86021
1
PHOSPHORUS URINE 24H
84105
1
ADRENAL ANTIBODY TITER
86256
1

ANTIDEPRESSANT(S)CONFIRM

BILL ONLY LEUK/LYMP EV
88184, 88185 (23), 88189
1

DEFINITIVE TEST 02

RFL Q FEVER IGG PHASE II
86638
1
RFLX ENDO AB IGA TITER
86256
1
D-LACTATE,PLSMA
83605
1
SCHISTOSOMA IGG SERUM
86682
1
TRICHINELLA IGG ABS
86784
1
FRANCISELLA TULARENSIS
86000
1
SOMATOSTATIN
84307
1
DEXAMETHASONE
80299
1
FECAL LIPIDS, TOTAL
82710
1
PROLACTIN, TOTAL/MONOM
84146 (2)
1
HERPESVIRUS 6 DNA
87532
1
HTLV I/II DNA, QUAL
87798 (2)
1
IODINE SERUM/PLASMA
82542
1
ASPERGILLUS AB,CF &
86606 (4)
1
BK VIRUS DNA, QN, URN
87799
1
ANTIMICROBIAL SUSCEPT
87181
1
THROMBOPOIETIN (TPO)
83520
1

14068

File details come from the government source that posted it. Updated .